Key result
Aspirin use for preeclampsia prevention was estimated among pregnant women with prepregnancy diabetes, obesity, and chronic hypertension from 2018 to 2020.
Aspirin use estimates in high-risk pregnancies may guide quality improvement; leaves open impact on preeclampsia incidence.
This study estimates aspirin use for preeclampsia prevention in pregnant women with prepregnancy diabetes, obesity, chronic hypertension, and combinations of these factors in 2018-2020.
No takes yet. Share an insight, caveat, or question.
Ray et al. (2022) studied this question. Aspirin use for preeclampsia prevention was estimated among pregnant women with prepregnancy diabetes, obesity, and chronic hypertension from 2018 to 2020.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: